AG
PBE icon

Advisor Group’s Invesco Biotechnology & Genome ETF PBE Stock Holding History

Advisor Group’s Portfolio PBE Stock Details PBE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$313K Sell
5,579
-925
-14% -$48.2K ﹤0.01% 2025
2019
Q3 		$307K Sell
6,504
-2,656
-29% -$136K ﹤0.01% 1990
2019
Q2 		$491K Sell
9,160
-2,995
-25% -$155K ﹤0.01% 1625
2019
Q1 		$670K Buy
12,155
+2,107
+21% +$111K 0.01% 1383
2018
Q4 		$473K Buy
10,048
+3,034
+43% +$156K ﹤0.01% 1442
2018
Q3 		$418K Buy
7,014
+1,455
+26% +$84.9K ﹤0.01% 1598
2018
Q2 		$304K Buy
5,559
+227
+4% +$11.5K ﹤0.01% 1675
2018
Q1 		$262K Sell
5,332
-1,264
-19% -$64.5K ﹤0.01% 1783
2017
Q4 		$311K Sell
6,596
-2,754
-29% -$129K ﹤0.01% 1670
2017
Q3 		$468K Sell
9,350
-1,565
-14% -$74.2K 0.01% 1248
2017
Q2 		$498K Buy
10,915
+56
+0.5% +$2.42K 0.01% 1146
2017
Q1 		$459K Sell
10,859
-757
-7% -$31.7K 0.01% 1130
2016
Q4 		$451K Sell
11,616
-1,837
-14% -$74.2K 0.01% 1074
2016
Q3 		$564K Sell
13,453
-2,584
-16% -$106K 0.01% 912
2016
Q2 		$590K Buy
+16,037
New +$629K 0.02% 836

Other funds holding PBE

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
PA
PFG Advisors Phoenix, Arizona $1.98B AUM 28.18% 1-Year Est. Return
BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

Advisor Group's PBE Position: Q4 2019 in Review

Advisor Group reduced its Invesco Biotechnology & Genome ETF (PBE) stake by 14% in Q4 2019, selling an estimated $48.2K and leaving 5,579 shares worth $313K. The position accounts for ﹤0.01% of the portfolio, ranked #2025.

Advisor Group first reported a position in PBE in Q2 2016 and has held it in 15 quarters since. The position peaked at $670K in Q1 2019. 78 funds tracked by Wall St. Rank hold PBE as of Q4 2019.

  • Advisor Group held 5,579 shares of Invesco Biotechnology & Genome ETF worth $313K as of Q4 2019.
  • Advisor Group sold 925 Invesco Biotechnology & Genome ETF shares in Q4 2019, an estimated $48.2K.
  • Invesco Biotechnology & Genome ETF made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #2025 holding.
  • Advisor Group first reported a position in Invesco Biotechnology & Genome ETF in Q2 2016 and has held it in 15 quarters since.
  • Advisor Group's Invesco Biotechnology & Genome ETF position peaked at $670K in Q1 2019.
  • 78 funds tracked by Wall St. Rank held Invesco Biotechnology & Genome ETF as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.